# Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

> **NCT03628092** · NA · UNKNOWN · sponsor: **Royal North Shore Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Vulvovaginal Atrophy
- Genitourinary Symptoms and Ill-Defined Conditions

## Interventions

- **DEVICE:** CO2 Fractional Ablative Laser
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT03628092
- **Lead sponsor:** Royal North Shore Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-24
- **Primary completion:** 2020-07-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628092, "Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03628092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*